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ABSTRACT
This article is co-authored by a patient with
colon cancer and his treating oncologist, who
interact at two different levels: the instrumental
and the emotional and affective one. The
patient relates in detail his personal
experiences struggling with cancer, including
his fears, expectations, purposes, and attitudes
through the most important events in the
evolution of his illness. The professional
reflects how patient-based communication and
shared decision-making impact on quality of
life and coping with cancer.
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THE PATIENT’S EXPERIENCE
In the following lines, I will attempt to show
how I feel and what my expectations and needs
are as a patient living with incurable cancer.
I am a 57-year-old man, a businessman,
social drinker, and I smoke one pack of
cigarettes per day with long periods of not
smoking. I cannot recall having had any kind of
illness during my life except for the odd flu.
My first symptoms appeared when, during
my daily commute to work, I had to stop the car
for some minutes, because of pain in my legs
that was all but unbearable. At first I thought it
might be an episode of temporary lumbago, so I
decided not to go to the doctor. During the
following weeks, other symptoms appeared
along with the previous ones: I had to get up
two or three time a night to urinate small
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amounts and later I had constipation and
bloody mucous in my feces. With these
symptoms, I started to read and consult
different sources on the Internet and
concluded that I had a serious illness—in fact,
I was sure that I had colon cancer.
I consulted a private physician and told him
about my symptoms and suspicions. A
colonoscopy was performed that detected a
tumor that filled 70% of the lumen of the
colon. The subsequent biopsy confirmed that it
was adenocarcinoma of the colon.
While it may seem strange, the diagnosis did
not discourage me; just the opposite. I was so
convinced that my concerns were now focused
on finding solutions. I think that with a disease
like this one, you derive your serenity and high
spirits from information. I believe that the
patient who is knowledgeable about their
illness can help their doctor in the treatment
process by maintaining a sensible dialogue with
them. Knowing what causes the symptoms, no
matter how serious the disease is, provides a
certain peace of mind and strength to fight. For
sure, during the first days, I wondered why this
had happened to me and I was invaded by fear.
Once all the tests were complete, the scanner
confirmed the presence of liver lesions and
possible peritoneal tumor implants.
Before a full month had gone by and with
the studies completed in the hospital in the city
where I live, I was thrilled to be given the date
for my colon surgery. Being familiar with the
hospital, its grandiose modern architecture, the
computer systems, how the doctors treated me,
and all the details I had observed had instilled
in me a sense of total trust.
After the operation, I was happy and
tremendously grateful to the surgeon who
even told me about the difficulties that had
arisen during the surgery, which had taken
several hours longer than usual. The pathology
report stated that there were no signs of
malignancy in the margins of the specimen
and that all the lymph notes that had been
removed were tumor-free, so I thought that the
first battle had truly been won.
In spite of everything, the presence of lesions
in the liver and peritoneum continued to concern
me, considering that I might need chemotherapy.
The situation made me so anxious that I could not
wait to see the oncologist. At that time, I intended
to pursue possible solutions to a situation with a
poor prognosis.
I finally met the oncologist! My partner went
with me to my appointment with the
oncologist, a great professional, head of a
department, and research project leader. He
explained to us that I have systemic disease and
that the only possible solution was
chemotherapy. He convinced us to participate
in a clinical trial. We asked him about the life
expectancy for someone in our situation, and
he answered that if left untreated, less than
1 year and with chemotherapy and the present
spread of the disease, I could easily last longer
than that. At that first visit, he did not seem
terribly approachable, which made it hard to
ask questions. We signed the consent form for
the trial and he gave us an appointment to start
chemotherapy. What I had heard did not worry
me. I intended to leave the doctor’s office and
begin to check out how true all the information
was using all the means within my reach. Again,
understanding new data and reading the
information about the study very carefully
kept me from becoming discouraged and
frustrated, as the doctor’s words might have
otherwise done. We went to the following
appointment with new knowledge and a
treatment plan that could improve my disease.
I had even consulted a surgeon because I did
not want to close any doors on a curative
treatment, liver and peritoneal surgery, even
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though I knew that I had few options. I had also
received information about a healthy lifestyle,
diet, and exercises to round out my fight against
cancer. The anticipation of being cured excited
me once again. All I needed was for the
chemotherapy to reduce the tumor mass.
Every time I went for chemotherapy or felt
exhausted or disabled by the cramping in my
hands and feet, I reminded myself that this
treatment was my choice and that gave me
strength for the fight.
After 3 months of treatment, the scanner
report confirmed an excellent response to
treatment with the liver metastases shrinking
by more than 50% and the peritoneal ones by
more than 80%.
Almost 6 months after the initial diagnosis, I
underwent surgery for the liver metastases and
later for the peritoneal implants.
Much sooner than expected, I relapsed. It
had not even been 2 months and the scanner
detected new implants in my peritoneum. I was
in a tricky situation and, what is more, the
oncologist we had seen previously was not
available, so an oncologist from the
department assessed us. When we spoke with
her, we were very fearful; however, we found
ourselves dealing with a warm person who
knew how to respond to and understand our
doubts. Without sidestepping the dismal truth,
she offered us a chemotherapy regimen, sharing
the treatment choice with us. She encouraged
us to set goals and fight to reach them.
Over the following 6 months, I underwent
two imaging studies that revealed that the
tumor was under control. I have later
continued with a maintenance treatment plan
that allows me to go to work for a few hours
every day and to live with my family almost
normally. The doctor brings me up to date
regularly about the progress being made in
treatments and has pointed us to interesting
websites of oncological societies or patient
associations. I have recently agreed to
participate in a study on lifestyle and diet that
is being coordinated by the head nurse at the
day hospital. Likewise, I try to help other
patients and support them, just as my family
supported me.
It has been 2 years since my diagnosis and I
do not know how much longer I will live. What
I do know is that so far, my fight has been
worthwhile. Although I have had to give up a
lot of things along the way, the most important
things—my family, my friends, and my work—
have stayed with me and have helped me in
everything much more and much better than I
could have ever dreamt. Other people with
whom I have crossed paths since the diagnosis,
my oncologist, the nursing staff at the day
hospital, and countless other professionals,
have been key and they have given me great
confidence, knowing that I put my life in their
hands with every new treatment or medical
decision.
PHYSICIAN’S PERSPECTIVE
Cancer is a major health problem worldwide
and carries a huge impact for the patient. The
diagnosis is typically unexpected, causing
psychological distress in virtually all patients,
including uncertainty, disbelief, despair,
vulnerability, fear, anxiety, and the need to
confront work, economic, family, and
psychosocial consequences. Furthermore, in
recent decades, improved diagnostic
techniques and the availability of multiple
treatments, including various chemotherapy
schemes and molecular-targeted drugs, can
lower mortality and improve prognosis.
All of this involves complicated
decision-making, a process during which, as
oncologists, we must interact with the patients
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on a high emotional level; take them into
account when deciding on the treatment plan,
and integrating their perspectives, concerns,
and preferences. Moreover, patients interact
with their physicians in very different ways
and become involved in the process in different
ways as well, depending on factors that have to
do with the doctor’s communication style, their
coping style, and other motivations.
Patient-based decision-making models seek
not only to increase satisfaction but also to
improve their coping, quality of life, and the
clinical course of disease. This patient is an
educated businessman with a proactive attitude,
looking for information and alternatives. It was
therefore imperative to help him understand; to
resolve all the doubts that arose for him along
the way, and provide him with the best sources
to consult, something that, nowadays, should
include scientific and patient association
websites, as the patient mentioned.
Because of the diagnosis of advanced,
unresectable, and disseminated cancer, surgery
alone would not suffice to cure the cancer;
hence, the rush to consult with oncology.
An important part of the initial
communication centers on explanations about
the tumor, prognosis, need for chemotherapy,
treatment plan, and managing toxicity.
Typically, the chemotherapy options available
are discussed, taking into account the benefits
and possible disadvantages. This then becomes
the foundation on which to make consensual,
individualized decisions. Whenever available,
clinical trials are the best option for patients
who must receive clear information about the
trial’s aim and all the procedures involved.
As in most patients, having advanced,
incurable cancer arouses enormous uncertainty
and an initial feeling of loss of control that, if
they persist, can have a direct, negative effect
on coping with the illness. The uncertainty
arises from the ominous perception of the
future or from the doctor’s failure to convey
effective information about where they are at in
the process, possibly as a result of
communication barriers (conspiracy of silence,
emotional blockage, the professional’s skill,
etc.).
It is important to be mindful of the fact that
the physician and patient interact in two main
spheres: the technical, scientific, or
instrumental one, as well as the domain that
focuses on the patient’s emotional and affective
aspects. Although an important part of the
communication centers on the detailed
exchange of practical information about the
treatment, the patient is going to react strongly
to this information on an emotional level and
other social, family, or affective aspects are
going to be put on the table. Instrumental
communication is the foundation of medicine
and, as such, should be positively valued by
patients, instilling into them trust in their
doctor. However, in oncology, the emotional
and/or affective component is more important
than in other fields, given the connotations of
cancer. Though both the technical and
emotional aspects are positively correlated,
patients give greater weight to the latter.
Oddly, this often means that patients do not
assess their doctors on their technical abilities,
but on their emotional competence to relate to
them. Since patients prioritize emotional
information, one approach associated with
favorable results is the so-called patient-based
communication model, with both an affective
and a participative component. In practice, it
involves the following attitudes: the
professional needs to show an affective
component (empathy, concern, reassuring
tone of voice, etc.) and to take into account
the patient’s preferences, perspectives, and
values, since they should be involved in
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deciding on the treatment plan, through
unhurried explanations, the use of open-ended
questions, etc.
In short, patient-based communication, in
this case a patient with advanced, incurable
cancer, and shared decision-making about the
advisability of starting chemotherapy have a
psychological impact and affect their quality of
life, coping, and the course of the disease;
hence, the patient’s biopsychosocial
environment must be understood, and
empathy and openness to dialogue must be
shown.
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